4.22 USD
↗ 0.19 (4.71%)AT CLOSE (11:59 AM EDT)
Foghorn Therapeutics Inc. Common Stock
FHTXNASDAQ • USD
4.22
↘ 0.01 (0.12%)
POST MARKET (AS OF 05:26 PM EDT)
Post Market
AS OF 05:26 PM EDT
4.22
↘ 0.01 (0.12%)
Market: CLOSED
Foghorn Therapeutics Inc. Common Stock (FHTX) trades at $4.22 per share. FHTX shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (98.6%) and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 26, 2026.
Open?$4.01
High?$4.29
Low?$3.98
Prev. Close?$4.03
Volume?1.2M
Avg. Volume?200.7K
VWAP?$4.13
Rel. Volume?6.11x
Bid / Ask
Bid?$3.45 × 100
Ask?$4.95 × 100
Spread?$1.50
Midpoint?$4.20
Valuation & Ratios
Market Cap?247.8M
Shares Out?58.7M
Float?33.4M
Float %?56.9%
P/E Ratio?N/A
P/B Ratio?-3.24
EPS?-$1.28
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
Themes
Employees
106
Market Cap
236.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-10-23
Address
500 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
Phone: 617-586-3100
CAMBRIDGE, MA 02139
Phone: 617-586-3100
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?83
Short Sent.?48
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.09Distress
Confidence?46%Low
Short InterestHigh
Short % of Float?4.17%Low
Short Interest?1.4M
Days to Cover?8.6
Free Float33.4M
Avg Daily Volume162.9K
Settlement Date2026-06-15
Financial Health
Current Ratio?2.90Strong
Quick Ratio?2.90Strong
Cash Ratio?1.36Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score75/100
P/E?N/A▾
P/B?-3.24CHEAP▾
S&P97
P/S?8.78HIGH▾
Peers100
S&P10
P/FCF?N/A▾
EV/EBITDA?-2.1CHEAP▾
S&P97
EV/Sales?5.67FAIR▾
Peers100
S&P30
Returns & Efficiency
ROE?98.6%STRONG▾
Peers50
S&P97
ROA?-33.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-87419000
Enterprise Value?$160.1M
Fundamentals ratios updated end of day